On June 9, 2025, ReShape Lifesciences Inc. announced a public offering of 1,054,604 shares of common stock at $2.50 per share, expecting to raise gross proceeds of approximately $2.6 million. This follows their prior issuance under an ATM offering, totaling about $3.6 million sold to date, leaving about $3.4 million available under the offering.